Supplementary Tables 3, 4, 5 and 6: data from <b>­­­</b><i>GAS6 and AXL promote insulin resistance by rewiring insulin signaling and increasing insulin receptor trafficking to late endosomes</i>

Supplementary Tables 3, 4, 5 and 6: data from the phosphoproteomic analysis presented in <i>GAS6 and AXL promote insulin resistance by rewiring insulin signaling and increasing insulin receptor trafficking to late endosomes</i>, by Schott et al. 2023.List of supplementary tables Supp Table 3 List of phosphopeptides for which quantitative data was obtained Supp Table 4 List of phosphopeptides with significant changes in any condition (P&lt;0.05 and fold change of &gt;1.4 or &lt;1.4) Supp Table 5 List of phosphopeptides significantly changes by insulin vs. untreated (P&lt;0.05 and fold change of &gt;1.4 or &lt;1.4) Supp Table 6 List of phosphopeptides significantly changed when comparing insulin vs. insulin in combination with GAS6 (P adj&lt;0.05 and fold change of &gt;1.4 or &lt;1.4) Legend of "contrast" column (red) I : Untreated I15: 15 min insulin treatment G: 24h GAS6 treatment IG15: 24h GAS6 + 15 min insulin treatment